Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMJAJSJ)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Clobutinol hydrochloride; Silomat; Biotertussin; Petoxil; Pertoxil; Silom; 1215-83-4; UNII-N2U6799DZQ; Clobutinol HCl; KAT 256; EINECS 214-931-7; Clobutinol hydrochloride [JAN]; N2U6799DZQ; 2-(p-Chlorobenzyl)-3-dimethylaminomethyl-2-butanol hydrochloride; 1-p-Chlorophenyl-2,3-dimethyl-4-dimethylamino-2-butanol hydrochloride; Benzeneethanol, 4-chloro-alpha-(2-(dimethylamino)-1-methylethyl)-alpha-methyl-, hydrochloride; p-Cloro-alpha-(2-(dimetilamino)-1-metiletil)-alpha-metil fenetil alcool cloridrato [Italian]
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||
|
||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Prostate
Prostate carcinoma
|
||||||||||||||||||||||||||||||||||||||||||
